当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Tomasz J. Stefaniak, Joanna Dziedziul, Anna M. Walerzak, Magdalena Stadnyk, Arfan Sheikh, Monika Proczko-Markuszewska, Dariusz Laski, Ad J. J. M. Vingerhoets, Dariusz K. Zadrozny, Irmina Anna Smietanska and Andrzej J. Lachinski
Purpose: Patients with pancreatic malignancy suffer from intractable and persistent pain that can only be effectively treated by the use of opioids. Such pain significantly impacts quality of life and becomes the stigma of the disease and dying. The aim of the study was to evaluate the psychosocial correlates of pain among the pancreatic cancer patients, with a special emphasis on social support.
Methods: One hundred and thirty one patients (52 women and 79 men) diagnosed with pancreatic cancer participated in the study. Visual Analog Scale (VAS) was used to assess current pain intensity. Social support was assessed by the subscale “Family and social living” of FACT–G and the Visual Representation Scale PRISM.
Results: There was a strong correlation between pain intensity and the social support measured by subscale of FACT-G in the opioid-using group (measured by VAS r=0.47, p<0.05) and measured with the PRISM (r=0.81, p<0.05). In the opioid-naïve group, there was no relationship between pain and perceived social support level. In women, pain strongly correlated with social support: VAS/FACT correlation was r=-0.64, VAS/PRISM r=-0.62 (both p<0.05).
Conclusions: In patients suffering from pancreatic cancer that use opioids, higher level of pain is connected with higher perceived positive impact of illness on social relations and with higher level of perceived social support. In contrary, in female patients, lower social support is associated with higher level of pain. Social support is an important contributor to pain perception in patients receiving opioids and in female patients.